You are here

AFM based nanoscale IR Spectroscopy (AFM-IR) as a characterization platform for P

Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 2R42GM100657-02
Agency Tracking Number: R42GM100657
Amount: $976,728.00
Phase: Phase II
Program: STTR
Solicitation Topic Code: 300
Solicitation Number: PA13-235
Timeline
Solicitation Year: 2014
Award Year: 2015
Award Start Date (Proposal Award Date): 2014-12-01
Award End Date (Contract End Date): 2017-11-30
Small Business Information
325 CHAPALA ST.
Santa Barbara, CA 93101-3407
United States
DUNS: 556921620
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 LYNNE TAYLOR
 (765) 496-6614
 lstaylor@purdue.edu
Business Contact
 LYNNE TAYLOR
Phone: (765) 496-6614
Email: lstaylor@purdue.edu
Research Institution
 PURDUE UNIVERSITY
 
155 S GRANT STREET
WEST LAFAYETTE, IN 47907-2114
United States

 Nonprofit College or University
Abstract

DESCRIPTION provided by applicant Anasys Instruments and Prof Lynne Taylor of Purdue propose to develop nanoscale chemical characterization capabilities for drug formulation research This project will build on successful Phase I research demonstrating feasibility of atomic force microscope based infrared spectroscopy AFM IR in pharmaceutical applications This Phase II research will advance techniques for efficiently determining morphological and chemical properties of nanostructured drug formulations leading to improvements in drug solubility This project will overcome key limitations of existing characterization tools includin the limitations of current AFM IR technology The proposed research will provide a critical new characterization tool for pharmaceutical research will enable a large commercial and research market and is expected to have significant downstream impacts on improving drug solubility and efficacy PUBLIC HEALTH RELEVANCE Anasys Instruments and Prof Lynne Taylor of Purdue propose to develop nanoscale chemical characterization capabilities for drug formulation research This project will build on successful Phase I research demonstrating feasibility of atomic force microscope based infrared spectroscopy AFM IR in pharmaceutical applications This Phase II research will advance techniques for efficiently determining morphological and chemical properties of nanostructured drug formulations leading to improvements in drug solubility

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government